Neutrophil Ratio May Predict Alzheimer's Risk Years in Advance
Event summary
- NYU Langone Health researchers identified a correlation between elevated neutrophil to lymphocyte ratio (NLR) and increased risk of Alzheimer's disease and related dementias.
- The study analyzed NLR data from nearly 400,000 patients across two healthcare systems, including 285,000 from NYU Langone and 85,000 from the Veteran's Health Administration.
- The elevated NLR was observed *before* any signs of cognitive impairment, suggesting a potential role in disease progression.
- The study found a higher risk associated with elevated NLR in Hispanic patients and women across both healthcare systems.
The big picture
This research highlights the growing recognition of immune system dysfunction as a potential driver of neurodegenerative diseases. The ease of NLR measurement from standard blood tests offers a potentially low-cost, accessible screening tool, but its predictive power will depend on further validation and integration with other risk factors. The findings underscore the shift towards preventative and early intervention strategies in Alzheimer's disease management, which could significantly impact healthcare spending and patient outcomes in the future.
What we're watching
- Ethnic Disparities
- The observed higher risk in Hispanic patients warrants further investigation to determine if genetic or socioeconomic factors are contributing to the correlation, potentially impacting screening strategies.
- Clinical Validation
- The NLR's utility as a diagnostic tool will depend on validation in larger, more diverse patient cohorts and its integration with existing risk assessment models.
- Therapeutic Targets
- The VIDA lab's research into neutrophil activity's role in dementia progression could reveal novel therapeutic targets, although establishing causality remains a significant hurdle.
Related topics